| Medius AG - FLUAD, Injektionssuspension | | 58317 | | 06 | | FLUAD | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 21.09.2012 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) 15 µg et neuraminidasum inactivatum (Virus strain A/California/7/2009 (H1N1)-like: Reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2) 15 µg et neuraminidasum inactivatum (Virus strain A/Victoria/361/2011 (H3N2)-like: Reassortant virus IVR-165), haemagglutininum influenzae B 15 µg et neuraminidasum inactivatum (Virus strain B/Wisconsin/1/2010-like: Reassortant NYMC BX-39 derived from B/Hubei-Wujiagang/158/2009).
adjuvans MF59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum.
excipients: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabilia q.s. to suspension for 0.5 ml. | | Packungsbestandteile | | Suspension injectable | | | |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
